+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atrial Septal Defect Market - Global Forecast 2026-2032- Product Image
Atrial Septal Defect Market - Global Forecast 2026-2032- Product Image
Sale

Atrial Septal Defect Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5313855
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atrial Septal Defect Market is projected to reach USD 4.58 Billion in 2026. It is expected to continue growing at a CAGR of 7.53%, reaching USD 7.10 Billion by 2032.

Atrial septal defect (ASD) is among the most common congenital heart defects, with published congenital heart disease literature consistently identifying ASD as a leading acyanotic lesion and estimating congenital heart disease overall at roughly 8 per 1,000 live births. ASD management spans fetal and pediatric cardiology, adult congenital heart disease programs, echocardiography, catheter-based structural heart intervention, cardiac surgery, and long-term rhythm and pulmonary vascular surveillance.

The atrial septal defect landscape is being shaped by earlier diagnosis, wider use of transthoracic and transesophageal echocardiography, increased adult detection, and strong clinical preference for minimally invasive closure when anatomy is suitable. Secundum ASD remains the principal target for transcatheter closure, while primum, sinus venosus, and complex defects continue to require specialist surgical assessment.

Transformative Shifts in the ASD Landscape

The most important shift in atrial septal defect care is the movement from symptom-driven treatment to lifecycle management. Children diagnosed through screening and imaging can be followed before right heart dilation progresses, while adults increasingly enter care after incidental imaging, arrhythmia evaluation, stroke workup, or assessment of unexplained exercise intolerance.

Technology is also changing the treatment pathway. Contemporary occluder devices, improved delivery systems, 3D echocardiography, intracardiac echocardiography, and hybrid imaging have expanded the number of patients evaluated for catheter-based ASD closure. At the same time, guideline-based selection remains critical because pulmonary hypertension, deficient rims, associated anomalous pulmonary venous return, and non-secundum anatomy can shift care toward surgery or conservative management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence atrial septal defect care through image acquisition support, automated chamber quantification, workflow triage, and clinical decision support. In echocardiography, AI-enabled tools can help standardize measurements of right atrial and right ventricular size, shunt-related remodeling, and image quality, areas where inter-operator variability can affect referral and follow-up decisions.

The cumulative impact of AI is likely to be highest when combined with expert review rather than used as a stand-alone diagnostic authority. Hospitals and medical technology developers are exploring AI for patient identification from electronic health records, procedural planning, post-closure surveillance, and registry analytics. Adoption will depend on validation across pediatric and adult populations, transparent algorithms, cybersecurity, regulatory clearance, and integration into congenital heart disease workflows.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East & Africa

In Asia-Pacific, demand is supported by large pediatric populations, expanding echocardiography capacity, and rapid growth of tertiary cardiac centers in China, India, Japan, South Korea, Australia, and ASEAN economies. The region’s atrial septal defect care pathway is increasingly shaped by public-sector pediatric cardiac programs, private hospital investment, and broader availability of catheterization laboratories, although rural access and affordability remain uneven. North America remains a high-adoption region for transcatheter ASD closure because of mature structural heart programs, adult congenital heart disease networks, regulated medical device pathways, and strong reimbursement infrastructure in the United States and Canada.

Europe benefits from established congenital heart disease registries, evidence-based clinical guidelines, regulated medical technology pathways, and cross-border clinical expertise, particularly within Western Europe and the European Union. Latin America, led by Brazil and Mexico, shows improving access to pediatric cardiology and interventional cardiology, although cost sensitivity and uneven specialist distribution remain important constraints. The Middle East is investing in advanced cardiac centers across GCC markets, while Africa faces the greatest access gap, with late diagnosis, limited catheterization capacity, constrained specialist availability, and reliance on mission-based or public-sector cardiac surgery in many countries.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are expanding congenital heart disease capacity through public hospital investment, private cardiac centers, and regional referral networks, although access varies significantly between Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. GCC countries are prioritizing specialty cardiac infrastructure, medical tourism, and government-funded access, making the region strategically relevant for ASD devices, imaging systems, and clinician training programs.

The European Union offers a regulated, evidence-oriented environment for atrial septal defect diagnosis and closure, with emphasis on clinical outcomes, device safety, interoperability, and post-market surveillance. BRICS countries combine large patient pools with heterogeneous access, creating opportunities for value-based device strategies, local manufacturing alignment, training partnerships, and referral network development. G7 markets lead in advanced imaging, adult congenital care, structured reimbursement, and AI-enabled workflow adoption, while NATO member countries overlap substantially with high-income healthcare systems that emphasize cardiac readiness, specialty care access, resilient medical supply chains, and standardized procurement practices.

Key Country Insights for Atrial Septal Defect Care

The United States leads in structural heart intervention, adult congenital heart disease specialization, and clinical adoption of advanced imaging for ASD closure planning. Canada benefits from universal healthcare pathways and strong pediatric cardiac centers, while Mexico and Brazil show rising access in major urban hospitals but remain sensitive to device cost, reimbursement variability, and specialist availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature congenital cardiology ecosystems supported by specialist centers, echocardiography capacity, and guideline-based care, with Germany and France also contributing strongly to device evaluation and imaging innovation. Russia has specialized cardiac centers but faces procurement and regional access variability. In Asia-Pacific, China and India represent high-volume care needs driven by population scale and expanding cardiac infrastructure; Japan, South Korea, and Australia emphasize quality, regulatory rigor, advanced imaging-supported intervention, and structured follow-up for pediatric and adult congenital heart disease patients.

Actionable Recommendations for ASD Industry Leaders

Industry leaders should align ASD strategies with evidence-based patient selection, anatomical suitability, and lifecycle follow-up rather than positioning closure as a one-size-fits-all intervention. Medical device developers should invest in deliverability, retrievability, pediatric sizing options, imaging compatibility, and long-term safety evidence, while hospitals should strengthen multidisciplinary heart teams that include pediatric cardiologists, adult congenital specialists, interventionalists, surgeons, anesthesiologists, and imaging experts.

Commercial teams should prioritize physician education, echo-lab standardization, registry participation, and market access evidence that demonstrates reduced morbidity, shorter hospital stays, and durable closure outcomes where clinically appropriate. AI vendors should focus on validated use cases such as automated chamber measurement, patient triage, procedural workflow support, and follow-up adherence, supported by transparent performance data across age groups and diverse healthcare settings.

Research Methodology

This executive summary is built from secondary research and evidence synthesis across peer-reviewed congenital heart disease literature, cardiology society guidance, public health sources, regulatory databases, hospital practice patterns, and medical technology adoption trends. Key reference domains include epidemiology of congenital heart disease, ASD classification and treatment pathways, transcatheter closure evidence, echocardiography standards, and adult congenital heart disease management.

The methodology emphasizes triangulation rather than single-source interpretation. Regional, group, and country insights are assessed through healthcare infrastructure maturity, specialist availability, reimbursement environment, regulatory readiness, procedural capacity, and adoption of imaging, catheterization, and AI-enabled clinical workflows. Only data-backed and clinically accepted concepts are used; speculative market claims, company-level comparisons, market sizing, market share, and unverified numerical estimates are excluded.

Conclusion

Atrial septal defect care is moving toward earlier detection, minimally invasive intervention, data-driven follow-up, and stronger integration between pediatric and adult congenital heart disease services. The best-positioned organizations will combine proven devices, expert imaging, clinical education, and regional access strategies that address both high-income and underserved healthcare systems.

Artificial intelligence, advanced echocardiography, and improved occluder technology will enhance the ASD care pathway, but clinical judgment and guideline-based selection will remain central. Long-term progress in the atrial septal defect market will depend on safe closure outcomes, equitable access, reimbursement evidence, and the ability to identify untreated patients before complications such as right heart enlargement, arrhythmia, pulmonary hypertension, or paradoxical embolism develop.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Atrial Septal Defect Market, by Product Type
7.1. Introduction
7.2. Cardiopulmonary Bypass Devices
7.3. Closure Devices
7.3.1. Occluder Devices
7.3.1.1. Balloon-Expandable Occluders
7.3.1.2. Self-Expanding Occluders
7.3.2. Surgical Patches
7.3.2.1. Biologic Patches
7.3.2.2. Synthetic Patches
7.4. Diagnostic Devices
7.4.1. Cardiac Catheterization Equipment
7.4.2. Cardiac Imaging Systems
7.4.3. Echocardiography Systems
8. Atrial Septal Defect Market, by Treatment Type
8.1. Introduction
8.2. Interventional Treatment
8.3. Non-Interventional Treatment
9. Atrial Septal Defect Market, by Age Group
9.1. Introduction
9.2. Adult
9.3. Pediatric
10. Atrial Septal Defect Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cardiac Centers
10.4. Hospitals
11. Atrial Septal Defect Market, by Defect Type
11.1. Introduction
11.2. Coronary Sinus
11.3. Ostium Primum
11.4. Ostium Secundum
11.5. Sinus Venosus
12. Atrial Septal Defect Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Atrial Septal Defect Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Atrial Septal Defect Market, by Country
14.1. United States
14.2. Germany
14.3. China
14.4. United Kingdom
14.5. India
14.6. Japan
14.7. Russia
14.8. Brazil
14.9. Canada
14.10. Italy
14.11. Mexico
14.12. France
14.13. Spain
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Asklepion Pharmaceuticals, LLC
16.3. atHeart Medical AG
16.4. B. Braun Medical Inc.
16.5. Boston Scientific Corporation
16.6. Carag AG
16.7. Edwards Lifesciences
16.8. GE HealthCare Technologies, Inc.
16.9. Koninklijke Philips N.V.
16.10. Lepu Medical Technology (Beijing) Co., Ltd
16.11. Lifetech Scientific
16.12. Occlutech GmbH
16.13. Visionary Medtech Solutions
16.14. W. L. Gore & Associates, Inc.
16.15. Weigao Meidcal international Co., Ltd
List of Figures
FIGURE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CLOSURE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CLOSURE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SURGICAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SURGICAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SURGICAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CORONARY SINUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CORONARY SINUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CORONARY SINUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SINUS VENOSUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SINUS VENOSUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SINUS VENOSUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 108. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 111. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 112. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 113. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 114. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 115. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 116. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 128. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 131. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 132. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 133. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 134. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 135. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 136. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 142. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 143. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 144. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 145. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 146. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 147. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 149. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 151. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 152. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 153. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 154. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 155. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 156. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 157. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 169. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 171. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 172. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 173. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 174. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 175. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 176. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 177. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 178. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 179. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 182. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 183. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 184. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 185. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 186. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 187. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 189. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 190. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 192. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 193. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 194. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 195. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 196. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 197. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 210. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 213. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 214. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 215. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 216. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 217. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 218. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 220. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 221. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 222. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 223. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 224. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 225. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 226. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 227. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 228. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 240. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 242. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 243. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 244. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 245. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 246. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 247. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 248. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 250. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 251. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 253. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 254. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 255. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 256. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 257. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 258. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 265. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 266. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 275. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 276. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 277. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 278. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 280. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 283. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 284. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 285. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 286. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 287. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 288. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 290. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 293. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 294. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 295. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 296. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 297. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 298. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 300. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 302. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 303. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 304. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 305. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 306. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 307. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 308. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 310. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 311. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 313. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 314. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 315. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 316. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 317. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 318. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 320. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 323. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 324. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 325. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 326. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 327. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 328. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 330. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 331. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 332. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 333. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 334. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 335. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 337. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 338. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 339. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 340. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 341. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 342. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2017-2032 (USD MILLION)
TABLE 343. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2017-2032 (USD MILLION)
TABLE 344. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2017-2032 (USD MILLION)
TABLE 345. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 346. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2017-2032 (USD MILLION)
TABLE 347. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 348. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2017-2032 (USD MILLION)
TABLE 350. GLOBAL ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 351. GLOBAL ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Asklepion Pharmaceuticals, LLC
  • atHeart Medical AG
  • B. Braun Medical Inc.
  • Boston Scientific Corporation
  • Carag AG
  • Edwards Lifesciences
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology (Beijing) Co., Ltd
  • Lifetech Scientific
  • Occlutech GmbH
  • Visionary Medtech Solutions
  • W. L. Gore & Associates, Inc.
  • Weigao Meidcal international Co., Ltd

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.58 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.1 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Atrial Septal Defect Market Report 2026 - Product Image

Atrial Septal Defect Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Aprindine Market - Global Forecast 2026-2032 - Product Image

Aprindine Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Atrial Fibrillation - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Atrial Fibrillation - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Anticoagulants Market - Global Forecast 2026-2032 - Product Image

Anticoagulants Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Hypertrophic Cardiomyopathy Treatment Market Report 2026 - Product Image

Hypertrophic Cardiomyopathy Treatment Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Atrial Septal Defect Drug Market

Atrial Septal Defect (ASD) is a type of congenital heart defect that affects the walls of the heart. It is one of the most common types of congenital heart defects, and is typically treated with drugs. Cardiovascular drugs are used to treat ASD, and include antiarrhythmic drugs, anticoagulants, and diuretics. Antiarrhythmic drugs are used to regulate the heart rate and rhythm, while anticoagulants are used to prevent blood clots. Diuretics are used to reduce fluid buildup in the lungs. The Atrial Septal Defect Drug market is a subset of the larger Cardiovascular Drugs market. It is a rapidly growing market, driven by the increasing prevalence of ASD and the need for effective treatments. The market is highly competitive, with a number of major players offering a range of products. Some of the leading companies in the Atrial Septal Defect Drug market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.